[go: up one dir, main page]

DD129652A5 - Verfahren zur herstellung der kristallinen alpha-form von 2-eckige klammer auf 4-(2-furoyl)-piperazin-1-yl eckige klammer zu-4-amino-6,7-dimethoxy-chinazolin-hydrochlorid - Google Patents

Verfahren zur herstellung der kristallinen alpha-form von 2-eckige klammer auf 4-(2-furoyl)-piperazin-1-yl eckige klammer zu-4-amino-6,7-dimethoxy-chinazolin-hydrochlorid

Info

Publication number
DD129652A5
DD129652A5 DD7700197618A DD19761877A DD129652A5 DD 129652 A5 DD129652 A5 DD 129652A5 DD 7700197618 A DD7700197618 A DD 7700197618A DD 19761877 A DD19761877 A DD 19761877A DD 129652 A5 DD129652 A5 DD 129652A5
Authority
DD
German Democratic Republic
Prior art keywords
chinazoline
clamber
furoyl
dimethoxy
piperazine
Prior art date
Application number
DD7700197618A
Other languages
German (de)
English (en)
Inventor
Ernest J Bianco
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of DD129652A5 publication Critical patent/DD129652A5/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/02Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DD7700197618A 1976-03-01 1977-03-01 Verfahren zur herstellung der kristallinen alpha-form von 2-eckige klammer auf 4-(2-furoyl)-piperazin-1-yl eckige klammer zu-4-amino-6,7-dimethoxy-chinazolin-hydrochlorid DD129652A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/662,937 US4092315A (en) 1976-03-01 1976-03-01 Novel crystalline forms of prazosin hydrochloride

Publications (1)

Publication Number Publication Date
DD129652A5 true DD129652A5 (de) 1978-02-01

Family

ID=24659839

Family Applications (1)

Application Number Title Priority Date Filing Date
DD7700197618A DD129652A5 (de) 1976-03-01 1977-03-01 Verfahren zur herstellung der kristallinen alpha-form von 2-eckige klammer auf 4-(2-furoyl)-piperazin-1-yl eckige klammer zu-4-amino-6,7-dimethoxy-chinazolin-hydrochlorid

Country Status (32)

Country Link
US (1) US4092315A (fr)
JP (1) JPS604188B2 (fr)
AR (1) AR210937A1 (fr)
AU (1) AU506937B2 (fr)
BE (1) BE851878A (fr)
BG (1) BG29724A3 (fr)
CA (1) CA1068269A (fr)
CH (1) CH618436A5 (fr)
CS (1) CS191332B2 (fr)
DD (1) DD129652A5 (fr)
DE (1) DE2708192C3 (fr)
DK (1) DK145858C (fr)
ES (1) ES8707447A1 (fr)
FI (1) FI62082C (fr)
FR (1) FR2372828A1 (fr)
GB (1) GB1538713A (fr)
HK (1) HK30881A (fr)
HU (1) HU173641B (fr)
IE (1) IE44522B1 (fr)
IL (1) IL51481A (fr)
LU (1) LU76868A1 (fr)
MY (1) MY8100271A (fr)
NL (1) NL169591C (fr)
NO (1) NO146499C (fr)
NZ (1) NZ183450A (fr)
PL (1) PL105559B1 (fr)
PT (1) PT66227B (fr)
RO (1) RO73095A (fr)
SE (1) SE423234B (fr)
SU (1) SU644387A3 (fr)
YU (1) YU41294B (fr)
ZA (1) ZA77918B (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX5483E (es) * 1977-08-04 1983-08-23 Abbott Lab Procedimiento para la preparacion del dihidrato clorhidrato de 1-(4-amino-6,7-dimetoxi-2-quinazolinil)-4-(2-tetrahidrofuroil)piperazina
GB1591490A (en) * 1977-08-04 1981-06-24 Abbott Lab 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-tetrahydrofuroyl)piperazine hydrochloride dihydrate
US4197301A (en) * 1978-10-16 1980-04-08 Allergan Pharmaceuticals, Inc. Topical ophthalmic use of Prazosin
FI67699C (fi) * 1979-01-31 1985-05-10 Orion Yhtymae Oy Foerfarande foer framstaellning av 6,7-dimetoxi-4-amino-2-(4-(2-furoyl)-1-piperazinyl)kinazolinhydroklorid med blodtryckssaenkande verkan
US4440769A (en) * 1983-02-11 1984-04-03 Abbott Laboratories 2-(4-Phenylalkanoylpiperazin-1-yl) quinazoline compounds, pharmaceutical compositions and method of producing α1 antagonistic activity
FI79107C (fi) * 1984-06-25 1989-11-10 Orion Yhtymae Oy Foerfarande foer framstaellning av stabil -form av prazosinhydroklorid.
US5322943A (en) * 1985-09-12 1994-06-21 The Upjohn Company Piperazine compounds which are substituted
US4601897A (en) * 1985-11-06 1986-07-22 Pfizer Inc. Prazosin-pirbuterol combination for bronchodilation
DE3683760D1 (de) * 1986-03-21 1992-03-12 Heumann Pharma Gmbh & Co Kristalline, wasserfreie sigma -form von 2-(4-(2-furoyl-(2-piperazin)-1-yl)-4-amino-6,7-dimethoxychinazolinhydrochlorid und verfahren zu ihrer herstellung.
US5110927A (en) * 1987-12-31 1992-05-05 The United States Of America As Represented By The Department Of Health And Human Services Prazosin analog with increased selectivity and duration of action
JP2652272B2 (ja) * 1990-12-31 1997-09-10 住化ファインケム株式会社 1−(4−アミノ−6,7−ジメトキシ−2−キナゾリニル)−4−(2−テトラヒドロフロイル)ピペラジン塩酸塩の新規な結晶体および該結晶体の製造方法
GB9417310D0 (en) * 1994-08-27 1994-10-19 Pfizer Ltd Therapeutic agents
US5952003A (en) * 1996-08-01 1999-09-14 Novartis Corporation Terazosin capsules
EP0849264A1 (fr) * 1996-12-20 1998-06-24 HEUMANN PHARMA GmbH Nouvelle forme polymorphique de mésylate de doxazosin (forme I)
EP0849266B8 (fr) * 1996-12-20 2007-10-03 Heumann PCS GmbH Nouvelle forme polymorphique de mésylate de doxazosin (forme III)
EP0849265A1 (fr) * 1996-12-20 1998-06-24 HEUMANN PHARMA GmbH Nouvelle forme polymorphique de mésylate de doxazosin (forme II)
EP3172377B1 (fr) 2014-07-21 2018-09-12 KEIR Manufacturing, Inc. Banc à broches aérodynamique

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3663706A (en) * 1969-09-29 1972-05-16 Pfizer Use of 2,4-diaminoquinazolines as hypotensive agents

Also Published As

Publication number Publication date
HU173641B (en) 1979-07-28
CH618436A5 (fr) 1980-07-31
BE851878A (fr) 1977-08-29
IL51481A0 (en) 1977-04-29
DE2708192B2 (de) 1979-08-02
FI62082B (fi) 1982-07-30
NL169591B (nl) 1982-03-01
FI770634A (fr) 1977-09-02
YU41294B (en) 1987-02-28
DE2708192A1 (de) 1977-09-08
FR2372828A1 (fr) 1978-06-30
DK145858C (da) 1983-09-12
NZ183450A (en) 1979-03-16
CS191332B2 (en) 1979-06-29
JPS604188B2 (ja) 1985-02-01
NO770674L (no) 1977-09-02
CA1068269A (fr) 1979-12-18
PL196354A1 (pl) 1978-02-27
FI62082C (fi) 1982-11-10
ES8707447A1 (es) 1987-08-16
SE7701624L (sv) 1977-09-02
DK145858B (da) 1983-03-21
PL105559B1 (pl) 1979-10-31
SU644387A3 (ru) 1979-01-25
NO146499C (no) 1982-10-13
GB1538713A (en) 1979-01-24
NL169591C (nl) 1982-08-02
DK86877A (da) 1977-09-02
HK30881A (en) 1981-07-10
PT66227B (en) 1978-07-14
FR2372828B1 (fr) 1980-02-01
ZA77918B (en) 1977-12-28
ES545368A0 (es) 1978-06-01
DE2708192C3 (de) 1980-05-08
JPS52105206A (en) 1977-09-03
BG29724A3 (en) 1981-01-15
AU2244377A (en) 1978-11-23
NL7702123A (nl) 1977-09-05
RO73095A (fr) 1981-06-26
LU76868A1 (fr) 1977-09-21
US4092315A (en) 1978-05-30
IE44522B1 (en) 1981-12-30
AR210937A1 (es) 1977-09-30
MY8100271A (en) 1981-12-31
PT66227A (en) 1977-03-01
YU49977A (en) 1983-12-31
IL51481A (en) 1980-09-16
IE44522L (en) 1977-09-01
SE423234B (sv) 1982-04-26
NO146499B (no) 1982-07-05
AU506937B2 (en) 1980-01-31

Similar Documents

Publication Publication Date Title
DD129652A5 (de) Verfahren zur herstellung der kristallinen alpha-form von 2-eckige klammer auf 4-(2-furoyl)-piperazin-1-yl eckige klammer zu-4-amino-6,7-dimethoxy-chinazolin-hydrochlorid
DD129006A5 (de) Verfahren zur herstellung von pyrimidinderivaten
DD138313A5 (de) Verfahren zur herstellung von alkenderivaten
DD134526A5 (de) Verfahren zur herstellung von alkyloxinderivaten der 7-aminothiazolylazetamidozephalosporansaeure
DD134519A5 (de) Verfahren zur herstellung von n'-eckige klammer auf 4-(phenethyloxy)-phenyl eckige klammer zu-n-methyl-n-methoxyharnstoffen
DD137225A5 (de) Verfahren zur herstellung von 1,2,4-triazin-5-on-derivaten
AT345266B (de) Verfahren zur herstellung von neuen substituierten n-alkyl-2,4-dinitro-6-trifluormethyldiphenylaminen
AT353796B (de) Verfahren zur herstellung von 3,4-dihydro-2- (1h)-chinazolinonen und 3,4-dihydro-2(1h)- chinazolinthionen
DD135905A5 (de) Verfahren zur herstellung von harnstoffderivaten
LU79591A1 (de) Verfahren zur herstellung von benzimidazol-derivaten
AT358007B (de) Verfahren zur herstellung von neuen n-(4-iso- hexylcyclohexylcarbonyl)-aminosaeurederivaten
DD135488A5 (de) Verfahren zur herstellung von pyridazinon-derivaten
DD132492A5 (de) Verfahren zur herstellung von n-(1-allyl-2'-pyrrolidylmethyl)-2,3-dimethoxy-5-sulfamoylbenzamid und seinen derivaten
AT353276B (de) Verfahren zur herstellung von 3,4-dihydro-2(1h) -chinazolinon-derivaten
DD137926A5 (de) Verfahren zur herstellung von n-substituierten alpha-ketocarbonsaeureamiden
DD137353A5 (de) Verfahren zur herstellung von uracilderivaten
LU79290A1 (de) Verfahren zur herstellung von chinazolin-derivaten
DD129790A5 (de) Verfahren zur herstellung von phenylpiperazinderivaten
DD131927A5 (de) Verfahren zur herstellung cancerostatisch und immunstimulierend wirkender 1-(n-acyl-carbamoyl)-2-cyanaziridine
ATA313780A (de) Verfahren zur herstellung von 4-(substituierten) thio-1-b-d-ribofuranosylpyrazolo(3,4-d)pyrimidinderivaten
DD137228A5 (de) Verfahren zur herstellung von 4-(1-hydroxy-1-methylaethyl)-3-cyclohexen-1-on-ketalen
DD134522A5 (de) Verfahren zur herstellung von 1,2,4-triazin-5-on-derivaten
ATA486078A (de) Verfahren zur herstellung von 1-(4-isopropyl- mercaptophenyl)-2-n-octylaminopropanol
AT366664B (de) Verfahren zur herstellung von neuen n-(3-arylthioureido)-phthalimiden
DD133671A1 (de) Verfahren zur herstellung von 6,7-dimethoxy-4-amino-2-eckige klammer auf 4-(2-furoyl)-1-piperazinyl eckige klammer zu chinazolin